Thrombolysis in Elderly Stroke Patients in Italy "TESPI"


Phase N/A Results N/A

Summary of Purpose

To collect efficacy and safety data on alteplase (rt-PA) in patients aged more than 80 years old, to demonstrate that the treatment of these patients within 3 hours of ischemic stroke onset with rt-PA compared to patients receiving standard treatment, will result in an improved clinical outcome with a favourable benefit/risk ratio.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 December 2010.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



  • No-profit study founded by the AIFA - Agenzia Italiana del Farmaco (Italian Medicines Agency, for the Drug approval and vigilance)

Trial Design

National, multicenter, randomized, open label vs standard treatment controlled trial in Italy.


Not available